We are live on
!
Find out more
MAA
Matrix Asset Advisors Portfolio holdings
AUM
$1.23B
1-Year Est. Return
26.4%
This Fund
S&P 500
This Quarter
Est. Return
+2.62%
1 Year Est. Return
+26.4%
3 Year Est. Return
+76.91%
5 Year Est. Return
+80.77%
10 Year Est. Return
+258.88%
AUM
$569M
AUM Growth
-$21M
(-3.6%)
Cap. Flow
-$32.9M
Cap. Flow
% of AUM
-5.79%
Top 10 Holdings %
Top 10 Hldgs %
38.07%
Holding
76
New
1
Increased
23
Reduced
30
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$6.28M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.61M |
| 3 |
PepsiCo
PEP
|
+$1.2M |
| 4 |
United Parcel Service
UPS
|
+$1.18M |
| 5 |
Gilead Sciences
GILD
|
+$1.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$9.46M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$7.37M |
| 3 |
Gen Digital
GEN
|
+$4.31M |
| 4 |
Morgan Stanley
MS
|
+$3.8M |
| 5 |
TE Connectivity
TEL
|
+$3.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.38% |
| 2 | Healthcare | 17.57% |
| 3 | Technology | 15.31% |
| 4 | Energy | 12.5% |
| 5 | Industrials | 10.88% |
Similar funds
WCM
IC
IA
IB
FLII
CNAM
NHAS
HCA
Matrix Asset Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Matrix Asset Advisors held 76 positions worth $569M, down 3.6% from $590M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Matrix Asset Advisors withdrew a net $32.9M in Q1 2017, closing 9 positions and reducing 30 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $9.46M position sold in full.
By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Matrix Asset Advisors opened a new position in Colgate-Palmolive worth $203K.
- Matrix Asset Advisors's largest Q1 2017 buy was Colgate-Palmolive: 2,775 shares worth $203K.
- Matrix Asset Advisors added most to CVS Health in Q1 2017, an estimated $6.28M increase.
- Matrix Asset Advisors's biggest Q1 2017 reduction was Gen Digital, cutting an estimated $4.31M.
- Matrix Asset Advisors fully exited Teva Pharmaceuticals in Q1 2017, selling an estimated $9.46M.
- Matrix Asset Advisors's ten largest holdings make up 38% of its $569M portfolio in Q1 2017.
- Matrix Asset Advisors opened 1 new position and closed 9 in Q1 2017.
- Matrix Asset Advisors's portfolio value fell 3.6% quarter-over-quarter to $569M.
Based on Matrix Asset Advisors's 13F filing for Q1 2017, filed 10 May 2017.